Literature DB >> 29941643

Molecular Identification and Susceptibility Testing of Molds Isolated in a Prospective Surveillance of Triazole Resistance in Spain (FILPOP2 Study).

Ana Alastruey-Izquierdo1,2, Laura Alcazar-Fuoli3,2, Olga Rivero-Menéndez3, Josefina Ayats4,2, Carmen Castro5, Julio García-Rodríguez6, Lidia Goterris-Bonet7, Elisa Ibáñez-Martínez8, María José Linares-Sicilia9, M Teresa Martin-Gomez7, Estrella Martín-Mazuelos5, Teresa Pelaez10, Javier Peman8, Antonio Rezusta11, Susana Rojo12, Rocio Tejero9, Diego Vicente Anza13,14,15, Jesús Viñuelas11, Maria Soledad Zapico13, Manuel Cuenca-Estrella3.   

Abstract

Antifungal resistance is increasing by the emergence of intrinsically resistant species and by the development of secondary resistance in susceptible species. A previous study performed in Spain revealed levels of azole resistance in molds of between 10 and 12.7%, but secondary resistance in Aspergillus fumigatus was not detected. We used itraconazole (ITZ)-supplemented medium to select resistant strains. A total of 500 plates supplemented with 2 mg/liter of ITZ were sent to 10 Spanish tertiary hospitals, and molecular identification and antifungal susceptibility testing were performed. In addition, the cyp51A gene in those A. fumigatus strains showing azole resistance was sequenced. A total of 493 isolates were included in the study. Sixteen strains were isolated from patients with an infection classified as proven, 104 were isolated from patients with an infection classified as probable, and 373 were isolated from patients with an infection classified as colonization. Aspergillus was the most frequent genus isolated, at 80.3%, followed by Scedosporium-Lomentospora (7.9%), Penicillium-Talaromyces (4.5%), Fusarium (2.6%), and the order Mucorales (1%). Antifungal resistance was detected in Scedosporium-Lomentospora species, Fusarium, Talaromyces, and Mucorales Three strains of A. fumigatus sensu stricto were resistant to azoles; two of them harbored the TR34+L98H mechanism of resistance, and the other one had no mutations in cyp51A The level of azole resistance in A. fumigatus remains low, but cryptic species represent over 10% of the isolates and have a broader but overall higher range of antifungal resistance.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Aspergillus; Fusarium; Mucorales; Scedosporium; TR34/L98H; antifungal resistance; aspergillosis; azole resistance; cryptic species; cyp51A

Mesh:

Substances:

Year:  2018        PMID: 29941643      PMCID: PMC6125503          DOI: 10.1128/AAC.00358-18

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  45 in total

Review 1.  The global problem of antifungal resistance: prevalence, mechanisms, and management.

Authors:  David S Perlin; Riina Rautemaa-Richardson; Ana Alastruey-Izquierdo
Journal:  Lancet Infect Dis       Date:  2017-07-31       Impact factor: 25.071

2.  Cryptic species in Stachybotrys chartarum.

Authors:  Michael Cruse; Robin Telerant; Thomas Gallagher; Thomas Lee; John W Taylor
Journal:  Mycologia       Date:  2002 Sep-Oct       Impact factor: 2.696

3.  Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complex.

Authors:  Abdullah M S Al-Hatmi; Anne D van Diepeningen; Ilse Curfs-Breuker; G Sybren de Hoog; Jacques F Meis
Journal:  J Antimicrob Chemother       Date:  2014-12-23       Impact factor: 5.790

4.  Prevalence and susceptibility testing of new species of pseudallescheria and scedosporium in a collection of clinical mold isolates.

Authors:  Ana Alastruey-Izquierdo; Manuel Cuenca-Estrella; Araceli Monzón; Juan L Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2006-11-13       Impact factor: 5.191

5.  Aspergillus citrinoterreus, a new species of section Terrei isolated from samples of patients with nonhematological predisposing conditions.

Authors:  Jesús Guinea; Marcelo Sandoval-Denis; Pilar Escribano; Teresa Peláez; Josep Guarro; Emilio Bouza
Journal:  J Clin Microbiol       Date:  2014-12-10       Impact factor: 5.948

Review 6.  Emerging fungal infections in solid organ transplant recipients.

Authors:  Shmuel Shoham
Journal:  Infect Dis Clin North Am       Date:  2013-04-17       Impact factor: 5.982

7.  Species identification and antifungal susceptibility patterns of species belonging to Aspergillus section Nigri.

Authors:  Laura Alcazar-Fuoli; Emilia Mellado; Ana Alastruey-Izquierdo; Manuel Cuenca-Estrella; Juan L Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2009-07-27       Impact factor: 5.191

8.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

9.  Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure.

Authors:  Susan J Howard; Dasa Cerar; Michael J Anderson; Ahmed Albarrag; Matthew C Fisher; Alessandro C Pasqualotto; Michel Laverdiere; Maiken C Arendrup; David S Perlin; David W Denning
Journal:  Emerg Infect Dis       Date:  2009-07       Impact factor: 6.883

Review 10.  Antifungal Susceptibility Testing of Fusarium: A Practical Approach.

Authors:  Abdullah M S Al-Hatmi; Ilse Curfs-Breuker; G Sybren de Hoog; Jacques F Meis; Paul E Verweij
Journal:  J Fungi (Basel)       Date:  2017-04-26
View more
  13 in total

1.  Multicentric Analysis of the Species Distribution and Antifungal Susceptibility of Cryptic Isolates from Aspergillus Section Fumigati.

Authors:  S Imbert; A C Normand; S Cassaing; F Gabriel; L Kristensen; C Bonnal; L Lachaud; D Costa; J Guitard; L Hasseine; M Palous; M Piarroux; M Hendrickx; R Piarroux; A Fekkar
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

2.  Molecular Identification, Antifungal Susceptibility Testing, and Mechanisms of Azole Resistance in Aspergillus Species Received within a Surveillance Program on Antifungal Resistance in Spain.

Authors:  Olga Rivero-Menendez; Juan Carlos Soto-Debran; Narda Medina; Jose Lucio; Emilia Mellado; Ana Alastruey-Izquierdo
Journal:  Antimicrob Agents Chemother       Date:  2019-08-23       Impact factor: 5.191

3.  Azole and Amphotericin B MIC Values against Aspergillus fumigatus: High Agreement between Spectrophotometric and Visual Readings Using the EUCAST EDef 9.3.2 Procedure.

Authors:  Pilar Escribano; Jesús Guinea; Julia Serrano-Lobo; Ana Gómez; Waldo Sánchez-Yebra; Miguel Fajardo; Belén Lorenzo; Ferrán Sánchez-Reus; Inmaculada Vidal; Marina Fernández-Torres; Isabel Sánchez-Romero; Carlos Ruiz de Alegría-Puig; José Luis Del Pozo; Patricia Muñoz
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

4.  Unravelling the Molecular Identification and Antifungal Susceptibility Profiles of Aspergillus spp. Isolated from Chronic Pulmonary Aspergillosis Patients in Jakarta, Indonesia: The Emergence of Cryptic Species.

Authors:  Anna Rozaliyani; Asriyani Abdullah; Findra Setianingrum; Wellyzar Sjamsuridzal; Retno Wahyuningsih; Anom Bowolaksono; Ayu Eka Fatril; Robiatul Adawiyah; Mulyati Tugiran; Ridhawati Syam; Heri Wibowo; Chris Kosmidis; David W Denning
Journal:  J Fungi (Basel)       Date:  2022-04-16

Review 5.  Emerging Fungal Infections: New Patients, New Patterns, and New Pathogens.

Authors:  Daniel Z P Friedman; Ilan S Schwartz
Journal:  J Fungi (Basel)       Date:  2019-07-20

Review 6.  Invasive Fusariosis in Nonneutropenic Patients, Spain, 2000-2015.

Authors:  Elena Pérez-Nadales; Ana Alastruey-Izquierdo; María José Linares-Sicilia; Juan Carlos Soto-Debrán; Edson Abdala; Julio García-Rodríguez; Miguel Montejo; Patricia Muñoz; Miguel Salavert Lletí; Antonio Rezusta; Maite Ruiz Pérez de Pipaón; Lucrecia Yáñez; Esperanza Merino; María Isolina Campos-Herrero; José María Costa-Mateo; Jesús Fortún; Tomás García-Lozano; Carolina Garcia-Vidal; Mario Fernández-Ruiz; Ferrán Sánchez-Reus; Carmen Castro-Méndez; Inmaculada Guerrero-Lozano; Pere Soler-Palacín; José María Aguado; Luis Martínez-Martínez; Julian Torre-Cisneros; Marcio Nucci
Journal:  Emerg Infect Dis       Date:  2021-01       Impact factor: 6.883

Review 7.  Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium.

Authors:  Amir Arastehfar; Toni Gabaldón; Rocio Garcia-Rubio; Jeffrey D Jenks; Martin Hoenigl; Helmut J F Salzer; Macit Ilkit; Cornelia Lass-Flörl; David S Perlin
Journal:  Antibiotics (Basel)       Date:  2020-12-08

Review 8.  zzm321990 Scedosporium and Lomentospora Infections: Contemporary Microbiological Tools for the Diagnosis of Invasive Disease.

Authors:  Sharon C-A Chen; Catriona L Halliday; Martin Hoenigl; Oliver A Cornely; Wieland Meyer
Journal:  J Fungi (Basel)       Date:  2021-01-04

9.  Azole-Resistant Aspergillus fumigatus Clinical Isolate Screening in Azole-Containing Agar Plates (EUCAST E.Def 10.1): Low Impact of Plastic Trays Used and Poor Performance in Cryptic Species.

Authors:  Julia Serrano-Lobo; Ana Gómez; Belén Rodríguez-Sánchez; Patricia Muñoz; Pilar Escribano; Jesús Guinea
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.191

10.  Point Mutations in the 14-α Sterol Demethylase Cyp51A or Cyp51C Could Contribute to Azole Resistance in Aspergillus flavus.

Authors:  Jose Lucio; Irene Gonzalez-Jimenez; Olga Rivero-Menendez; Ana Alastruey-Izquierdo; Teresa Pelaez; Laura Alcazar-Fuoli; Emilia Mellado
Journal:  Genes (Basel)       Date:  2020-10-17       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.